BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Leukemia
,
Endothelial cell
,
Anticancer prodrugs
,
Rosiglitazone
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
claudin 7
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Colon mucosa
Ileum mucosa
Ascending colon
Colon
Transverse colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Lichen
Periodontitis
Anomaly of chromosome pair 6
Disease of mouth
Sendai virus infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
4-nitrobenzoic acid
pulegone
ferrocene
4-chloro-2-nitroaniline
4-chloroaniline
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FIGLA
SNAI1
RPS2
ARID3A
MIR200A
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression.
Claudin-1 in Head and Neck Squamous Cell Carcinoma.
Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer.
Micro RNA-175 Targets Claudin-1 to Inhibit Madin-Darby Canine Kidney Cell Adhesion.
Claudin 7 suppresses invasion and metastasis through repression of a smooth muscle actin program.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Role of Urinary Claudin-2, Caveolin-1, and EGF as Diagnostic Biomarkers of Necrotizing Enterocolitis…
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advan…
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)
A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-sm…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ